| scholarly article | Q13442814 |
| P2093 | author name string | F Y Ma | |
| B J Rollins | |||
| G H Tesch | |||
| D J Nikolic-Paterson | |||
| E Ozols | |||
| F Y Chow | |||
| P2860 | cites work | Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 |
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities | Q28513582 | ||
| MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 | ||
| IKK-beta links inflammation to obesity-induced insulin resistance | Q29614285 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance | Q33997240 | ||
| Diabetic kidney disease in thedb/dbmouse | Q34195384 | ||
| Monocyte chemoattractant protein 1 in obesity and insulin resistance | Q35163496 | ||
| Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice | Q36375621 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth | Q37380502 | ||
| Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. | Q40765518 | ||
| Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4, and lipopolysaccharide. | Q41165230 | ||
| Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. | Q42804854 | ||
| Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle | Q43759228 | ||
| In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway | Q44024701 | ||
| Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy | Q44265195 | ||
| ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. | Q44526996 | ||
| Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury | Q44692955 | ||
| Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis | Q45170289 | ||
| Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice | Q46460973 | ||
| Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone | Q46620643 | ||
| Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice | Q46865455 | ||
| Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. | Q51554738 | ||
| Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. | Q52566078 | ||
| Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. | Q54223604 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| The role of macrophages in diabetic glomerulosclerosis | Q70704470 | ||
| Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice | Q73400431 | ||
| Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway | Q74770030 | ||
| Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis | Q78656070 | ||
| Production and release of macrophage migration inhibitory factor from human adipocytes | Q81089261 | ||
| P433 | issue | 2 | |
| P921 | main subject | obesity | Q12174 |
| type 2 diabetes | Q3025883 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 471-480 | |
| P577 | publication date | 2006-12-12 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. | |
| P478 | volume | 50 |
| Q34324553 | 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study |
| Q90307901 | ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions |
| Q36352141 | Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy |
| Q42641988 | Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice |
| Q50522405 | An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. |
| Q47733423 | Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice |
| Q43876702 | Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse |
| Q48395232 | Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis. |
| Q39009713 | Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases. |
| Q36666878 | Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics |
| Q54651740 | Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response |
| Q35558662 | BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses |
| Q89584780 | Beneficial Effects of Qingzixiaoban Granule on Henoch-Schönlein Purpura Nephritis Mice through Inhibiting Immune Complex Deposition and Th2 Immunodeviation |
| Q50089749 | Beneficial Effects of n-3 Fatty Acids on Cardiometabolic and Inflammatory Markers in Type 2 Diabetes Mellitus: A Clinical Trial |
| Q33620560 | C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria |
| Q42945868 | CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice |
| Q33816616 | CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice |
| Q40791151 | Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase |
| Q38495475 | Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. |
| Q35141424 | Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice |
| Q43174450 | Critical role for osteopontin in diabetic nephropathy |
| Q41854992 | Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. |
| Q61512392 | Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes |
| Q39370127 | Detection of adiponectin and monocyte chemoattractant protein-1 using a calixcrown derivatives-coated protein chip |
| Q34387952 | Diabetic nephropathy - complications and treatment |
| Q36589609 | Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis |
| Q38810830 | Dietary low-fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation. |
| Q41652967 | Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis |
| Q41854872 | Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. |
| Q37155484 | Effect of Regular Exercise on the Histochemical Changes of d-Galactose-Induced Oxidative Renal Injury in High-Fat Diet-Fed Rats |
| Q26825467 | Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases |
| Q37684896 | Emerging roles of hematopoietic cells in the pathobiology of diabetic complications |
| Q30482887 | Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet |
| Q50058406 | Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy |
| Q61648712 | Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice |
| Q41858296 | Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy |
| Q50903298 | High association of IL-4 gene intron 3 VNTR polymorphism with diabetic peripheral neuropathy. |
| Q38936622 | Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets |
| Q36645971 | Implications of treatment that target protective mechanisms against diabetic nephropathy |
| Q99579043 | In silico prediction and validation of potential therapeutic genes in pancreatic β-cells associated with type 2 diabetes |
| Q35821566 | Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats |
| Q41880267 | Induction of oxidative stress in kidney |
| Q26866480 | Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets |
| Q35904102 | Inflammation and oxidative stress in obesity-related glomerulopathy |
| Q47305480 | Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. |
| Q38042593 | Inflammation in diabetic nephropathy |
| Q38255902 | Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. |
| Q37871339 | Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. |
| Q39496640 | Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice |
| Q41788971 | Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. |
| Q91259809 | Macrophages: versatile players in renal inflammation and fibrosis |
| Q33699810 | Mechanisms of inflammatory responses in obese adipose tissue |
| Q39801451 | Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. |
| Q35439302 | Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling |
| Q38692630 | MicroRNA-29b inhibits diabetic nephropathy in db/db mice |
| Q80558926 | Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy |
| Q50956817 | Mixed compared with single-source proteins in high-protein diets affect kidney structure and function differentially in obese fa/fa Zucker rats. |
| Q36222092 | Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes |
| Q85225771 | Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy |
| Q38140956 | Monocyte chemoattractant protein-1 -2518G/A gene polymorphism and the risk of nephropathy in type 2 diabetes mellitus among Asians: a meta-analysis |
| Q41506750 | Mori cortex prevents kidney damage through inhibiting expression of inflammatory factors in the glomerulus in streptozocin-induced diabetic rats |
| Q42253708 | Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy. |
| Q43049709 | Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. |
| Q34836376 | Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy |
| Q64945155 | Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy. |
| Q38265818 | Novel effective drugs for diabetic kidney disease? or not? |
| Q33742301 | Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats |
| Q38298806 | Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1. |
| Q84742870 | Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition |
| Q47321983 | Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose‑treated HK‑2 cells |
| Q43286010 | Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. |
| Q43196259 | Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. |
| Q37819453 | Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy |
| Q36666799 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes |
| Q92824810 | Reduction in Urinary Chemokine (C-C Motif) Ligand 2 (CCL2) After Surgery-Induced Weight Loss |
| Q38842693 | Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats |
| Q82270824 | Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients |
| Q33963259 | Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet |
| Q38359435 | Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. |
| Q36863519 | Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain |
| Q54782198 | Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. |
| Q88035415 | Role of the Immune System in Diabetic Kidney Disease |
| Q35048727 | SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells |
| Q46979190 | Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-κB activation and MCP-1 and TGF-β1 expression in rat mesangial cells. |
| Q37174513 | Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. |
| Q36731626 | Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats |
| Q87462719 | Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients |
| Q37798716 | Systemic effects of white adipose tissue dysregulation and obesity-related inflammation |
| Q26852726 | Targeting inflammation in diabetes: Newer therapeutic options |
| Q38144642 | The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. |
| Q49499359 | The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy |
| Q34603718 | The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients |
| Q35079607 | Therapeutic targets for treating fibrotic kidney diseases |
| Q35720839 | Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy |
| Q64325743 | Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy |
| Q90216471 | Ubiquitin-Fold Modifier-1 Participates in the Diabetic Inflammatory Response by Regulating NF-κB p65 Nuclear Translocation and the Ubiquitination and Degradation of IκBα |
Search more.